Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

South Africa appeals over female classification rules

Published 23/06/2018, 16:13
Updated 23/06/2018, 16:20
South Africa appeals over female classification rules

CAPE TOWN (Reuters) - Athletics South Africa (ASA) have lodged an appeal with the Court of Arbitration for Sport (CAS) to halt the implementation of new female classification rules by the governing body of athletics (IAAF), the organisation confirmed on Saturday.

It follows a similar challenge by South Africa's double Olympic 800 metres champion Caster Semenya, who opposes new rules from the IAAF, requiring her to take medication to lower her higher than normal natural levels of testosterone.

The president of ASA, Aleck Skhosana is also set to meet with his IAAF counterpart Sebastian Coe "in the coming week" to discuss the new regulations, the South African body revealed.

"As a loyal member federation of the IAAF, ASA has a duty to protect all its athletes, including female athletes who may fall foul of these regulations," ASA said in a statement.

"ASA has engaged with the IAAF directly since May 10, 2018 declaring its intention to oppose the implementation of the regulations."

ASA added that their challenge is supported by the South African government and the country's Olympic committee and they have called for the immediate suspension of the implementation of the regulations until both appeals have been ruled on.

"ASA has also applied for the implementation of the regulations to be suspended pending the outcome of the CAS arbitration on the basis that there are prospects of success in the arbitration, and irreparable prejudice and harm will result if the regulations are implemented with effect from Nov. 1, 2018, and the balance of interests favours affected female athletes," the statement continued.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

ASA added they would instruct their legal and medical teams to also support the appeal of Semenya.

The IAAF said the regulations are based on peer-reviewed studies and observation by scientists which showed that females with above-normal or male equivalent levels of testosterone had up to a 12 percent performance advantage over fellow female athletes.

The IAAF also said they were ready to defend the new regulations at the court.

Testosterone is a hormone that increases muscle mass, strength and haemoglobin, which affects endurance. The IAAF rule is not directly aimed at Semenya but she will be most affected by it.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.